Business Case Studies, Leadership Case Study, Sanofi-Aventis: CEO Gerard Le Fur's Formula for Change

print page
Tell A Friend
Bookmark
 

Case Categories

Leadership Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Sanofi-Aventis: CEO Gerard Le Fur's Formula for Change

Publication Year : 2008

Authors: Amjad Khan, Rajendar Singh Rathore

Industry: Health Care

Region:Europe

Case Code: LDS0028

Teaching Note: Available

Structured Assignment: Available

Buy This Case Study
OR





Abstract:
Sanofi-Aventis, the world’s third biggest pharmaceutical company, focuses mainly on prescription drugs and human vaccines. Ever since the company’s establishment in 1973, the company had been following the inorganic growth strategy to mark its presence worldwide. Until recently, Sanofi remained reserved and never disclosed the details of the group’s portfolio of experimental drugs, thereby raising shareholders’ concerns. In addition, the company is uptight with growing competition from generic drug-makers. In January 2007, Sanofi had a major management reshuffle wherein, the company’s longest serving chairman and CEO Jean-Francois Dehecq, relinquished his CEO position to Gerard Le Fur while retaining chairmanship. Amid this situation, it remains to be seen whether Le Fur can sail the company through these troubled times.

Pedagogical Objectives:

    The case is structured to help the students understand:
  • Critical success factors in the pharmaceutical industry
  • Value chain of the pharma industry
  • Trends and challenges facing global pharmaceutical industry
  • Sanofi-Aventis’ new CEO Gerard Le Fur’s initiatives
  • Promoting a company insider vs appointing an outsider.

Keywords : Global Pharmaceutical Industry; Critical Success Factors; Value Chain of the Pharma industry, Acquisitions and Joint Ventures, Trends and Challenges in the Pharma Industry; Product Lifecycle Management; Jean-François Dehecq; Organisational Transformational Strategies; Restructuring - Turnaround Strategies Case Study; Leading Transformation; Pfizer; Glaxosmithline; Novartis; Clinical Research Outsourcing (CRO); Blockbuster Drugs; Successor’s Dilemma; Generic Drugmakers; FDA Regulations

Contents:

  • Global Pharmaceutical Industry – A Landscape
  • Growth of Sanofi-Aventis under Jean-François Dehecq
  • New CEO Gerard Le Fur's Initiatives

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • John P KotterJohn P Kotter

    John P Kotter, is a Konosuke Matsushita Professor of Leadership, Emeritus at Harvard Business School.
    Speaks on Leadership
  • Michael E MaccobyMichael E Maccoby

    Michael E Maccoby, is an President of The Maccoby Group in Washington, DC.
    Speaks on Leadership
  • Jim CollinsJim Collins

    Jim Collins, is a Founder of Management Laboratory in Boulder, Colorado
    Speaks on Level 5 Leadership
  • View All Executive Interviews»



Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2013 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap